Michelle Krogsgaard, M.Sc., PhD is an Associate Professor with tenure in the Department of Pathology and the co-leader of the Tumor Immunology Program at Perlmutter Cancer Center, as well as the graduate advisor for the Inflammation and Immunology Program. Dr. Krogsgaard received her Master of Science in Molecular Biology from the University of Copenhagen, where her main project focused on antibody engineering. She continued to study the role of antigen presentation in the pathogenesis of Multiple Sclerosis, completing her PhD in Molecular Biology and Immunology. As a postdoc, she studied the basic mechanisms of T cell signaling at Stanford University.
Her laboratory combines cell biology, biochemistry and biophysics to explore mechanisms of T cell recognition, activation, migration and T-cell effector functions in mouse models of disease and in human tissues to developing new therapies for cancer, viral and autoimmune disease. She serves on NIH/NCI study sections and have been continuously funded by the NIH during her independent career. Dr. Krogsgaard was an Alfred Benzon Fellow, a Pew Scholar in the Biomedical Sciences, an American Cancer Society Research Scholar, a Cancer Research Institute Investigator, received the Mark Foundation ASPIRE Award and was selected for the Exceptional, Unconventional, Research Enabling Knowledge Advancement (EUREKA) Innovator Award from the NIH.